Mini Bio-Anchor w/Needles
Navigation Links
Mini Bio-Anchor w/Needles
| Products | Mini Bio-Anchor w/Needles |
| Company | Arthrex |
| Item | Mini Bio-Anchor w/Needles |
| Features | |
| Description | The Mini Bio-Anchor with Needles is a 2.4 mm x 7 mm bioabsorbable implant that provides 120 Newtons of pull-out strength. The bioabsorbable, PLDLA amorphous copolymer anchor retains initial fixation strength throughout the tissue healing process, and undergoes a rapid degradation process. |
| Info | Arthrex Customer Service: (800) 933-7001 Web site: http://www.arthrex.com |
Related medicine products :
1. Bio-Anchor® Shoulder Instability Repair System
2. Bio-Corkscrew™ Suture Anchor w/Needles
Breaking Medicine News(10 mins):Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2
[0] Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance [0] New Blood Thinner Could Replace Warfarin to Fight Venous Clots[0] New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V)[0] Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists[0] Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference
Other Medicine News:Health News:Ultimate Destination of anti-depressant, Prozac 2Health News:PI-103 Effective against Brain Cancer 2Health News:PI-103 Effective against Brain Cancer 3Health News:Acetaminophen does not Protect Heart Muscle 2Health News:Acetaminophen does not Protect Heart Muscle 3Health News:Sanyo’s Electrolysed Water Technology Effective In Suppressing Bird Fl 2Health News:'Oncomodulin'- Path To Nerve Regeneration 2
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Johnson 26 Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 12681 1Johnson 26 Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 12681 2Johnson 26 Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 12681 3ORNL finding could help electronics industry enter new phase 49303 1ORNL finding could help electronics industry enter new phase 49303 2Does Botox 28R 29 Finally Have Competition 3F 49301 1Does Botox 28R 29 Finally Have Competition 3F 49301 2
[0] For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain[0] New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults[0] Van Andel Institute Cuts Ribbon on $178 Million Expansion
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |